Preview Mode Links will not work in preview mode
Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show offers a glimpse into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the evolving dynamics in the medical and healthcare landscape. One focus is on how providers, pharmaceutical companies, and payers are empowering patients.  In addition, conversations often focus on how technology is empowering providers, care facilities, pharmaceutical companies, and payers to improve patient outcomes and reduce friction across the healthcare landscape.  Popular Topics Include: Virtual and digital health Use of AI, ML, and robots for clinical and administrative purposes  Value-based healthcare  Precision and stratified medicine Next-generation immuno, cell, and gene therapies Vaccines for infectious diseases and oncology Biomarkers and diagnostics Rare diseases MedTech and medical devices Clinical trials  Population health Chronic conditions l Clinician and staff burnout Smart hospitals The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.
  1. All Episodes
  2. Attacking Fibrosis with Smart Drugs to Promote Faster Healing with Pierre Laurin Prometic Life Sciences

Attacking Fibrosis with Smart Drugs to Promote Faster Healing with Pierre Laurin Prometic Life Sciences

Jul 19, 2018

Pierre Laurin, B.Sc.Pharm., M.Sc is President and CEO, Prometic Life Sciences, a company working to address varying forms of fibrosis. Pierre points out how much researchers have learned about fibrosis just over the last 10 years and how it is more common than you may think attacking vital organs for a variety of reasons. We also learn about what Prometic is doing to tackle highly progressive fibrotic diseases such as idiopathic pulmonary fibrosis (IPF) and the ultra-rare condition Alström syndrome.

#fibrosis #ipf #alstromsyndrome  

Prometic Life Sciences